Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-05-30

Clinical Trial Update: Topical Gel Anti-Fungal Agent for Tinea Unguium [Phase 2]

View source ↗

Summary

A Phase 2 trial of a topical antifungal gel for onychomycosis (tinea unguium) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MediQuest topical antifungal gel

Snippet

Sponsor: MediQuest Therapeutics | Conditions: Onychomycosis | Phase 2 | Status: COMPLETED